statxact version 5 software (Cytel Software)
90
Structured Review
Cytel Software
statxact version 5 software
Statxact Version 5 Software, supplied by Cytel Software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statxact+software+version+5/statxact+software/pm20097511-86-10-15
Average 90 stars, based on 1 article reviews
Statxact Version 5 Software, supplied by Cytel Software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statxact+software+version+5/statxact+software/pm20097511-86-10-15
Average 90 stars, based on 1 article reviews
statxact version 5 software - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. Article Snippet: .. Exact 95% CIs were calculated around the observed incidences using Article Title: A simple diagnostic strategy in hospitalized patients with clinically suspected pulmonary embolism. Article Snippet: The incidences of symptomatic venous thromboembolism confirmed by objective testing in the group of patients in whom anticoagulant treatment was withheld were calculated for the groups of patients 2006 Blackwell Publishing Ltd Journal of Internal Medicine 260: 459–466 with (i) an unlikely CDR-score in combination with a normal D-dimer concentration or (ii) a helical CT scan that excluded pulmonary embolism. .. Exact 95% confidence intervals (CI) were calculated around the observed incidences using Article Title: Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Article Snippet: Materials and Methods: After Institutional Animal Care and Use Committee approval, retroperitoneal neuroblastomas were established in mice with unmodified NXS2 cells (n 13) or with cells engineered to overexpress an angiogenesis inhibitor—either tissue inhibitor of matrix metalloproteinase-3 (n 22) or a truncated soluble form of the vascular endothelial growth factor receptor-2 (truncated soluble fetal liver kinase-1; n 13).. When tumors were approximately 600 mm, contrast material–enhanced gray-scale US was performed, and the imaging was recorded on cine clips.. Regions of interest within tumors were analyzed off-line to determine postcontrast change in signal intensity (SI) from baseline to initial peak ( SI), rate of SI increase from baseline to initial peak (RSI), and contrast material washout. Article Title: Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism Article Snippet: s since January 1975, a full-text search capacity, and a personal archive for saving articles and search results of interest.. All articles can be printed in a format that is virtually identical to that of the typeset pages.. Beginning six months after publication, the full text of all Original Articles and Special Articles is available free to nonsubscribers who have completed a brief registration. Control:Article Title: Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism Article Snippet: s since January 1975, a full-text search capacity, and a personal archive for saving articles and search results of interest.. All articles can be printed in a format that is virtually identical to that of the typeset pages.. Beginning six months after publication, the full text of all Original Articles and Special Articles is available free to nonsubscribers who have completed a brief registration. other:Article Title: Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Article Snippet: During the past 2 decades, management of sickle cell anemia (SCA) has dramatically improved.. Treatments with stem cell transplantation (SCT) and hydroxyurea (HU) have been introduced, and supportive care, including pain management and psychosocial services, hasmarkedly improved.. Chronic transfusion (CT) remains an available and effective therapy, and the prospect of convenient oral chelation for iron-overloaded patients makes this approach more feasible [1,2]. |